Navigation Links
Frost & Sullivan Honors Clinical Ink for Developing an eSource Platform that Streamlines Clinical Development
Date:9/3/2014

MOUNTAIN VIEW, Calif., Sept. 3, 2014 /PRNewswire/ -- Based on its recent analysis of the eClinical solutions market, Frost & Sullivan recognizes Clinical Ink with the 2014 North American eClinical Solutions Award for Entrepreneurial Company of the Year. The award recognizes Clinical Ink's innovative SureSource® platform -- the  first purpose-built eSource solution that captures data electronically at the point of care.

Each year, Frost & Sullivan presents this award to the company that has demonstrated excellence in devising a strong growth strategy and robustly implementing it. The recipient has shown strength in terms of innovation in products and technologies, leadership in customer value, as well as speed in response to market needs.  In short, the award looks at the emerging market players in the industry and recognizes best practices that are positioned to fundamentally impact the clinical development process.

"The intuitive SureSource platform offers the freedom to work without regard to connectivity, while allowing fast and secure electronic transmission of source documents and data," said Jennifer Lazar, Frost & Sullivan Global Program Director, Life Sciences. "Clinical Ink's client and user satisfaction has been extremely positive, with nearly 80 percent of users claiming that SureSource positively affected their clinical trial process and that they are eager to use it again."

Clinical Ink is well-positioned to realize the FDA's vision of eliminating paper in the clinical trial process (FDA's recently released eSource guidance clearly "promotes" and "encourages" capturing data electronically).  The SureSource platform has been used in more than 50 studies worldwide and early adoption metrics show dramatic reductions in critical timelines and the potential to reduce monitoring cost by up to 50 percent. 

Unlike existing electronic data capture (EDC) platforms, SureSource allows site users to immediately capture data during the subject visit, using a tablet equipped with custom-built electronic source (eSource) forms.  Reflecting the clinical workflow of sites, SureSource eSource forms look just like traditional paper source, but incorporate sophisticated data validations and safeguards to clean data at the time it is initially captured.  The clinical data is immediately available for real-time, remote review by sites, sponsors, and CROs – a dramatic improvement from the weeks/months it can take in the traditional EDC model.  

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.

About Clinical Ink

With offices in Winston-Salem, NC and Philadelphia, PA, Clinical Ink is an innovation-driven eSource solutions company committed to delivering technology that makes clinical research easier for sites, sponsors, subjects and regulators.  Developers of SureSource®, the first purpose-built eSource platform that provides cleaner data faster, Clinical Ink is dedicated to eliminating paper documents in clinical research.  Additional information about Clinical Ink is available at www.clinicalink.com or by calling toll-free 800-301-5033.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:         Gain access to visionary innovation

Contact:

Mireya Espinoza
P: 210.247.3870
F: 210.348.1003
E: mireya.espinoza@frost.com

Alicia Maguire
P: 336.464.0696
E: alicia.maguire@clinicalink.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors
2. Needle-Free Delivery Devices Shape the Future of Vaccines, Says Frost & Sullivan
3. Frost & Sullivan: Change in Demographics and Surge in Domestic Manufacturing Drive Asia-Pacific Medical Devices Market
4. Frost & Sullivan Applauds Volpara Solutions Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer
5. Frost & Sullivan: Multi-Modality Breast Imaging Systems Spur Innovations in Europe
6. Frost & Sullivan: Healthcare Investor Focus on Malaysia Grows, Bolstered by Government Support and Medical Tourism
7. Frost & Sullivan Recognizes Baxano Surgical as a Leader in MIS Spine Innovation
8. Frost & Sullivan Honors Vitro Biopharma for its Outstanding Technological Innovations and Business Strategy in the Stem Cell Tools Industry
9. Frost & Sullivan Applauds F Cubed for its Game-Changing MRSA Screener, the NESDEP IU
10. Frost & Sullivan Honors Mobius Imaging for Developing a Mobile 32-Slice CT Scanner, the Airo Mobile Intraoperative CT
11. Frost & Sullivan Applauds MobileHelp for its Targeted Supplies for the PERS Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)...   , ... primären Endpunkte und demonstriert Ebenbürtigkeit bei der Gesamtreinigung ... plus guter , Reinigung des ...      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) , ... von der MORA-Studie der Phase III für NER1006 ...
(Date:5/24/2016)... 24, 2016  NxStage Medical, Inc. (Nasdaq: ... advancing renal care, today announced that Jeffrey H. ... the following schedule of investor conferences. Where applicable, a ... http://ir.nxstage.com/ .   ... NY, NY           Friday, June 10, 2016 1:30 p.m. ...
(Date:5/24/2016)... KONG , May 24, 2016 ... stent de doble terapia del mundo, introduce catéteres ... arteriovenosa. OrbusNeich, una compañía global especializada ... las vidas, ha expandido su cartera incluyendo productos ... balón JADE™ y Scoreflex™ PTA son los dispositivos ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... ... An April Gallup survey found rising health care costs to be the ... Senior Living (SHSL) may not share those same worries thanks to a new ... year, while holding the line on increasing their contributions, including premiums, deductibles and the ...
(Date:5/26/2016)... ... May 26, 2016 , ... Memorial Day Weekend marks ... Amica Insurance is sharing tips to make sure your family and vehicle are ... National Safety Council, there may be 439 deaths and an additional 50,500 serious injuries ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... treatment for eating disorders, is opening a brand new child and adolescent residential ... 8-17 and their families with even more specialized eating disorder treatment and access ...
(Date:5/26/2016)... ... May 26, 2016 , ... North Cypress Medical Center ... Golf Club in Cypress. With the help of community partners, the event organizers raised ... renews hope for wounded service members and their families through health, wellness, and therapeutic ...
(Date:5/26/2016)... ... May 26, 2016 , ... American ... chief medical officer of Blue Horizon International (BHI), Brian Mehling, M.D., spoke at ... held during May 5-6, 2016 in Chicago, IL, USA. Dr. Mehling’s presentation was ...
Breaking Medicine News(10 mins):